Results 171 to 180 of about 180,037 (267)
Pregnancy‐associated breast cancer (PrBC) presents therapeutic challenges. Understanding maternal–fetal safety of systemic anticancer therapies is critical. We performed a case/non‐case disproportionality analysis using the WHO global pharmacovigilance database up to January 2024, to evaluate maternal–fetal outcomes associated with breast cancer (BC ...
Rayan Kabirian +12 more
wiley +1 more source
Lactose quantification in human breast milk by gas chromatography - mass spectrometry. [PDF]
Berthiaume L +4 more
europepmc +1 more source
IMPAACT 2001 (NCT02651259) evaluated the safety and pharmacokinetics (PK) of once‐weekly isoniazid and rifapentine in pregnant and postpartum women for tuberculosis prevention. Rifapentine (RPT) and desacetyl rifapentine (desRPT) PK data were collected in maternal plasma, breast milk, infant cord blood, and infant plasma.
Priya Jayachandran +18 more
wiley +1 more source
Microbial Imprints of Gestational Diabetes Mellitus: Longitudinal Shifts in Breast Milk, Areola Skin, and Infant Gut. [PDF]
Hong Z +10 more
europepmc +1 more source
Advancing Pregnancy and Pediatric Science through the NIH Transporter Elucidation Network
Human gestation is characterized by dynamic changes in maternal physiology and maturation of tissue functions before and after birth. The fetus and neonate are highly dependent upon transfer of maternal nutrients via the placenta and lactating mammary gland, which frequently involve selective membrane transporter proteins.
Joanne Wang +16 more
wiley +1 more source
Effects of preterm birth and gestational diabetes on innate lymphoid cells (ILCs) in human breast milk. [PDF]
Raché M +6 more
europepmc +1 more source
Medication use during breastfeeding is common, yet data on drug transfer into breast milk and infant exposure remain limited. This study describes real‐world requests concerning medication compatibility with breastfeeding managed by the Lyon pharmacovigilance center over five years.
Blandine Bertin +8 more
wiley +1 more source
Transfer of trastuzumab and pertuzumab into human breast milk: a case report. [PDF]
Buitelaar PLM +6 more
europepmc +1 more source
Pregnant and breastfeeding individuals are routinely excluded from clinical drug development, creating persistent evidence gaps in pharmacology, safety, and dosing. Despite mandatory contraception and pregnancy testing, unintended pregnancies occur, particularly during the development of central nervous system (CNS) medicines used by women of ...
Sam Schoenmakers +4 more
wiley +1 more source

